aheadmedicine.comAbout company
AHEAD Medicine focuses on developing AI-enabled immunoprofiling diagnostic for cancer precision medicine. Our lead product is AHEAD-flow platform, a machine learning based, fully automated analysis tool for clinical cytometry exams on blood cancer patients that is 100 times faster than current method. Here is the demo of our prototype: https://youtu.be/qcom2_RBDsA We have published our works in multiple international congresses and peer-reviewed journals. Our full list of publication could be found here: https://aheadmedicine.com/publications We also have co-development projects with pharmaceutical companies for immuno-oncology companion/complementary diagnostics in the pipeline. Currently, we are raising an equity round to establish a quality management system, complete FDA pre-submission meeting and kick off external validation study for our leading product AHEAD-flow platform.
